Unlike CVS, Walgreens Has a Cure for Its Woes.

Subjects

Subjects :

STOCK prices
PHARMACY benefit management
GOING public (Securities)
FREE cash flow
INVESTORS

Details

Language :

English

Database :

Complementary Index

Journal :

Bloomberg Opinion

Publication Type :

Periodical

Accession number :

180389728